This case-based activity is designed to help pathologists and laboratory professionals increase their knowledge, skills, and competence in applying practice-changing updates regarding HER2-low and HER2-ultralow advanced breast cancer. Through three case-based microlearning activities learners will answer questions designed to help them carefully consider the nuances of HER2-low and HER2-ultralow breast cancer diagnosis. This is the second of the three activities and focuses on the emerging science of HER2-low and HER2-ultralow and current treatment for HER2-low and HER2-ultralow patients.
Course Topics Include:
- Emerging science around HER2-low and HER2-ultralow
- Current and evolving treatment strategies for patients with HER2-low and HER2-ultralow breast cancer
Target Audience
This activity has been designed to meet the educational needs of pathologists and laboratory professionals.
Learning Objectives
Upon completion of this activity, you will be able to:
- Describe the emerging science and clinical significance of low and ultra-low HER2 expression in breast cancer
- Evaluate current and evolving treatment strategies for patients with low and ultra-low HER2 expression
Faculty
Mamatha Chivukula
Director of Breast Pathology Services
MIlls Peninsula Medical Center, Burlingame, CA
Faculty Disclosures
Dr. Chivukula has no financial relationships to disclose.
Accreditation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
Credit Designation Statement
The ASCP designates this activity for a maximum of .25 AMA PRA Category 1 Credit(s)â„¢. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ASCP designates this activity for a maximum of .25 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CME credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.
Method of Participation
To complete the activity and receive credit, the participant must complete the program. CME certificates will be provided online.
Commercial Support
This activity is supported by independent educational grants from AstraZeneca Pharmaceuticals and Daiichi Sankyo, Inc.